INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

76,653 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
FL
Fu LuyangSr. VP, Chief Actuary - Sub
CINFCINCINNATI FINANCIAL CORP
Tax withholding
F$24K
147 sh
Apr 29, 2026May 1, 2026
Page 1029 of 1917
← PrevNext →
traded Apr 29, 2026
+2d
SEC Form 4

Evidence

9
LL
Lawver Teri LDirector
ALTAltimmune, Inc.
Grant or award
A—
48.8K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

9
SK
Snyder KristenDirector
BHRBBurke & Herbert Financial Services Corp.
Grant or award
A—
8,418 sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

9
TC
Tarvin Landon CPresident,UFP Retail Solutions
UFPIUFP INDUSTRIES INC
Grant or award
A$1,163
13 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
AD
Ackley DavidEVP
CACCAMDEN NATIONAL CORP
Tax withholding
F$5,299
110 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
SP
Sharma PankajChief Business Officer
RELYRemitly Global, Inc.
Grant or award
A—
118.4K sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

9
MH
Martel William HEVP
CACCAMDEN NATIONAL CORP
Tax withholding
F$7,579
158 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

9
PD
Poillon DianeDirector
BHRBBurke & Herbert Financial Services Corp.
Grant or award
A—
675 sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

9
FA
Forbes AndrewEVP
CACCAMDEN NATIONAL CORP
Tax withholding
F$4,672
97 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$190K
7,500 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

9
RB
Raths BarbaraEVP
CACCAMDEN NATIONAL CORP
Tax withholding
F$5,010
104 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
AB
Albert BenjaminDirector, CEO
HCATHealth Catalyst, Inc.
Tax withholding
F$417
310 sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

9
AR
Archer Michael REVP
CACCAMDEN NATIONAL CORP
Tax withholding
F$7,370
153 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
AD
Ackley DavidEVP
CACCAMDEN NATIONAL CORP
Tax withholding
F$6,284
131 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

8
SS
Sloan SheldonChief Medical Officer
SYRESpyre Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$2.15M
78.3K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

8
GJ
Gahlhoff Jerry Jr.Director, PRESIDENT & CEO
ROLROLLINS INC
Gift
G—
3,629 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

8
WJ
Wassil JimCHIEF OPERATING OFFICER
PCVXVaxcyte, Inc.
Open-market sale · 10b5-1 plan
SELL$128K
2,250 sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

7
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$78K
7,500 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

7
SS
Sloan SheldonChief Medical Officer
SYRESpyre Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
78.3K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

6
BL
Burrows Scott LChief Financial Officer
SYRESpyre Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$181K
12.5K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

5
HA
Hardy AndrewEVP, Chief Sales Officer
NXPINXP Semiconductors N.V.
Option exercise
M—
4,880 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

5
SR
Stangl RolfDirector
REYNReynolds Consumer Products Inc.
Grant or award
A—
10.7K sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

5
PE
Page Andrew EChief Financial Officer
ASAmer Sports, Inc.
Grant or award
A—
30.4K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

5
FA
Flees Lori AnnDirector, President & CEO
VVVVALVOLINE INC
Grant or award
A$1,927
58 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

5
SP
Sharma PankajChief Business Officer
RELYRemitly Global, Inc.
Grant or award
A—
15.3K sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

5
KC
Karlsson Jutta CGeneral Counsel
ASAmer Sports, Inc.
Grant or award
A—
5,180 sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

4
AI
Aoki IchiroDirector, President
INDIindie Semiconductor, Inc.
Option exercise · 10b5-1 plan
M—
100.0K sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

4
HT
Hamilton Brian TDirector, President of CCBX
CCBCOASTAL FINANCIAL CORP
Open-market sale · 10b5-1 plan
SELL$232K
3,079 sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

2
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Option exercise
M—
754 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

2
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Option exercise
M—
754 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

1
SA
Shafer AndrewChief Cust Mkt & Brnd Officer
GEVOGevo, Inc.
Open-market sale · 10b5-1 plan
SELL$11K
5,550 sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

0
SM
Stetz MattiasChief Operating Officer
RSIRush Street Interactive, Inc.
Disposition to issuer · 10b5-1 plan
D—
20.0K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

0
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Derivative conversion · 10b5-1 plan
C—
55.6K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

0
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Derivative conversion · 10b5-1 plan
C—
55.6K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

0
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Derivative conversion · 10b5-1 plan
C—
47.2K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

0
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Derivative conversion · 10b5-1 plan
C—
55.6K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

0
BL
Burrows Scott LChief Financial Officer
SYRESpyre Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

0
AI
Aoki IchiroDirector, President
INDIindie Semiconductor, Inc.
Option exercise · 10b5-1 plan
M—
100.0K sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

0
AI
Aoki IchiroDirector, President
INDIindie Semiconductor, Inc.
Option exercise · 10b5-1 plan
M—
100.0K sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

0
HT
Hamilton Brian TDirector, President of CCBX
CCBCOASTAL FINANCIAL CORP
Tax withholding · 10b5-1 plan
F$17K
230 sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence